Global Virus Network Adds Tulane University School of Medicine as Newest Center of Excellence

Baltimore, Maryland, USA, and Atlanta, GA, USA, Oct. 19, 2016: The Global Virus Network (GVN) and Tulane University School of Medicine announced today the induction of Tulane as GVN’s newest Center of Excellence. The GVN represents 38 Centers of Excellence and six affiliates in 25 countries and comprises foremost experts in every class of virus causing disease in humans.

The announcement was made by Robert Gallo, MD, co-founder and scientific director of GVN and Robert Garry, PhD, professor, Department of Microbiology and Immunology, assistant dean, Graduate Program in Biomedical Sciences, program manager, Viral Hemorrhagic Fever Consortium, Tulane University School of Medicine. Garry will be director of Tulane’s GVN Center of Excellence.

The new Tulane GVN Center of Excellence focuses on a number of aspects of viral pathogenesis. Tulane also leads the Viral Hemorrhagic Fever Consortium (VHFC), a public-private partnership of scientists who are developing countermeasures, including diagnostics, immunotherapeutics and vaccines, against Lassa virus, Ebola and Marburg viruses, flaviviruses (including Zika virus) and several other high consequence pathogens.

“Given their breadth and deep expertise in viruses, particularly hemorrhagic viruses, Tulane will be an excellent resource for the GVN,” said Gallo, who is co-discoverer of HIV and The Homer and Martha Gudelsky Distinguished Professor in Medicine, director, Institute of Human Virology, University of Maryland School of Medicine, a GVN Center of Excellence. “Bob Garry’s ability to establish successful public-private partnerships, such as the VHFC, to help bring lab research to the clinic, particularly in the field of diagnostics, will be a tremendous boost to the GVN.”

“We look forward to joining the GVN so that we can better foster infrastructure development, research, training and education on detection, prevention, amelioration, and treatment of viral hemorrhagic fever viruses targeting both the scientific and general communities,” says Garry. “We have a significant presence in West Africa and are pleased to extend our global reach through the GVN.”

The VHFC is a collaboration between Tulane, Scripps Research Institute (a GVN Center of Excellence), Harvard University/Broad Institute, University of Texas Medical Branch (a GVN Center of Excellence), Autoimmune Technologies LLC, Kenema Government Hospital (Sierra Leone), Redeemers University and the Irrua Specialist Teaching Hospital (Nigeria), Zalgen Labs, LLC, and various other partners in West Africa.

The GVN is a global authority and resource for the identification and investigation, interpretation and explanation, control and suppression, of viral diseases posing threats to mankind. It enhances the international capacity for reactive, proactive and interactive activities that address mankind-threatening viruses and addresses a global need for coordinated virology training, developing scholarly exchange programs for recruiting and training young scientists in medical virology. The GVN also serves as a resource to governments and international organizations seeking advice about viral disease threats, prevention or response strategies and GVN advocates for research and training on virus infections and their many disease manifestations.

About the Global Virus Network (GVN)

The Global Virus Network (GVN) is a non-profit, 501(c)(3) organization, comprised of leading medical virologists from 25 countries. The GVN’s mission is to combat current and emerging pandemic viral threats through international collaborative research, training the next generation of medical virologists, and advocacy. For more information, please visit www.gvn.org. Follow us on Twitter @GlobalVirusNews

About Tulane University School of Medicine

One of the nation’s most recognized centers for medical education, Tulane University School of Medicine is a vibrant center for education, research and public service. Tulane School of Medicine is the second-oldest medical school in the Deep South and the 15th oldest medical school in the United States. Tulane School of Medicine recruits top faculty, researchers and students from around the world, and pushes the boundaries of medicine with groundbreaking medical research and surgical advances. Tulane remains in the forefront of modern medical innovation and is equipping the next generation of medical professionals with the tools to succeed in the rapidly changing future of health care.

Global Virus Network and the Japanese Society for Virology (JSV) Host Meeting of Top Virologists From Around the World

Virus Researchers Descend Upon Sapporo to Address Rising Global Viral Threats
Sapporo, Japan, October 18, 2016: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, will hold its 8thmeeting in Sapporo, Japan October 23—25, 2016 in partnership with the Japanese Society for Virology (JSV), the National Institute of Infectious Diseases (NIID) of Japan and the Research Center for Zoonosis Control (CZC) at Hokkaido University. The announcement was made today by Robert Gallo, MD, GVN Co-Founder and Scientific Director, Hideki Hasegawa, MD, PhD, Director of the Department of Pathology of NIID and Hirofumi Sawa, MD, PhD, Deputy Director of CZC and Professor of Molecular Pathobiology at CZC. Both CZC and NIID comprise Japan’s GVN Center of Excellence which also includes the Institute of Medical Science of the University of Tokyo and the Institute for Virus Research (IVR) at Kyoto University.
“While viruses such as Zika dominate international headlines, researchers are continuously working vigorously behind the scenes to solve not only these critical current threats but dangerous imminent threats as well,” said Dr. Robert Gallo, co-discoverer of HIV as the cause of AIDS and Director of the Institute of Human Virology at the University of Maryland School of Medicine, a GVN Center of Excellence. “International meetings such as this one are an integral piece in solving these scientific challenges and forging global collaborations that might otherwise not exist.”
He continued, “I am especially pleased to co-host this year’s GVN meeting in Japan given my long-history with this great nation with my lab’s discovery in 1980 of a human retrovirus endemic in Japan and the only known human leukemia virus – HTLV. It is an important virus that will be discussed during our meeting as it can cause devastating symptoms and sometimes death.”
“Japan has proudly been a member of the GVN since its inception in 2011, and is honored to host our internationally renowned colleagues in an effort to advance global health,” said Dr. Hideki Hasegawa. “My colleagues at NIID and across Japan join me in welcoming GVN to Sapporo.”
This year’s GVN meeting includes a robust discussion with candid conversations on cutting-edge research such as Zika virus, HTLV-1, human papilloma virus (HPV), influenza, Ebola virus, Lassa virus, dengue virus, human immunodeficiency virus (HIV), hepatitis, chikungunya, among other viruses, and viral diagnostics.
“The JSV meeting’s 1400 registrants look forward to having the opportunity to have full access to the GVN sessions, thereby expanding opportunities for collaborative dialogue, particularly for researchers in Japan,” said Dr. Hirofumi Sawa.
“The interaction of GVN members and highlighting its activities with the many hundreds of Japanese virologists attending their own national meeting will demonstrate the international importance of the GVN and will provide a unique opportunity to establish new research collaborations,” said William Hall, MD, PhD, GVN Co-Founder, Professor of Microbiology at the University College Dublin, a GVN Center of Excellence, and Distinguished Professor in the CZC at Hokkaido University.
The GVN is an essential and critical defense against viral disease. It is a coalition comprised of world renowned virologists, all working to advance knowledge about how viruses cause disease, to develop drugs and vaccines to prevent illness and death, and to train the next generation of virus researchers. GVN is the only institution in the world that has expertise in all classes of human viruses.
For a full program please visit http://gvn.org/sapporo_2016/. One-on-one interviews can be arranged upon request and a press conference will be held Tuesday, October 25 at 12:00 pm at the Sapporo Convention Center, Rm 101. A simultaneous interpreter will be provided during the press conference. Tweet #GVNSapporo2016 and @GlobalVirusNews.
OFFICIAL PRESS CONFERENCE
*Simultaneous Interpreter will be provided
Time: October 25, 2016 at 12:00 pm
Where:

Sapporo Convention Center, Rm 101(1-1-1 Higashi-Sapporo 6-jo, Shiroishi-ku, Sapporo, 003-0006, Japan TEL: +81-11-817-1010)

What:

“Global Virus Network and the Japanese Society for Virology (JSV) Host Meeting of TopVirologists From Around the World: Virus Researchers Descend Upon Sapporo to Address Rising
Global Viral Threats”

Who:

Hideki Hasegawa, MD, PhD, Director, Department of Pathology, National Institute of Infectious
Diseases (NIID)
Robert Gallo, MD, Co-Founder & Scientific Director, Global Virus Network (GVN) and Director,
Institute of Human Virology, University of Maryland School of Medicine
Hiroshi Kida, DVM, PhD, Professor Emeritus, Head, Research Center for Zoonosis Control (CZC),
Hokkaido University
Scott Weaver, MS, PhD, Chair, GVN Zika Task Force and Director of the University of Texas Medical Branch’s Institute for Human Infections and Immunity and Scientific Director of the Galveston National Laboratory, a GVN Center of Excellence

CONTACTS
Hokkaido University Contact: Hirofumi Sawa, +81-11-7065185 or h-sawa@czc.hokudai.ac.jp
GVN Contact: Nora Grannell, +1 443 823 0613 or ngrannell@gvn.org

Hosts

[one_whole background-color=”white”][one_fourth boxed=”true”] black-logo-81[/one_fourth][one_fourth boxed=”true”] Hokkaido
[/one_fourth][one_fourth boxed=”true”] [/one_fourth][one_fourth_last] NIID-logo5[/one_fourth_last]

[/one_whole]

Global Virus Network Adds Emory University as a Center of Excellence

Baltimore, Maryland, USA, and Atlanta, GA, USA, Sept. 1, 2016: The Global Virus Network (GVN) and Emory University announced today the induction of Emory as GVN’s newest Center of Excellence. The GVN represents 37 Centers of Excellence and six affiliates in 25 countries and comprises foremost experts in every class of virus causing disease in humans.

The announcement was made by Robert Gallo, MD, co-founder and scientific director of GVN, Raymond Schinazi, PhD, DSc, the Frances Winship Walters Professor of Pediatrics and director of the Laboratory of Biochemical Pharmacology at Emory University, and Carlos del Rio, MD, the Hubert Professor and Chair of the Department of Global Health at the Rollins School of Public Health, professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine, and co-director of the Emory Center for AIDS Research (CFAR). Schinazi and del Rio will be co-directors of Emory’s GVN Center of Excellence.

Emory is renowned for its leading research programs that focus on various viruses including HIV/SIV, hepatitis B and C, dengue, herpes, Zika, influenza, norovirus, Ebola, chikungunya and West Nile viruses.

“Emory has broad outstanding virology and immunology research programs, but when it comes to HIV I know of no place with more serious contributors to the field than those at Emory,” said Gallo, who is co-discoverer of HIV and director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a GVN Center of Excellence.

“From Ray Schinazi and Dennis Liotta’s pioneering drug development, to Carlos del Rio and Susan Allen’s important epidemiology, clinical and prevention research with some of the most vulnerable populations, to the molecular virology work of Eric Hunter and Cynthia Derdeyn, to the fundamental immunology of Max Cooper and Rafi Ahmed, to the critical studies on HIV pathogenesis of Guido Silvestri, to the vaccinology science research of Mark Mulligan and Rama Amara and unforgettably the tremendous contributions from James Curran on the early epidemiology of HIV. It is about time to have this great university as part of the GVN.”

”It is an honor to be included in the Global Virus Network,” says Schinazi, “and we look forward to increased collaborations with researchers around the world that can lead to new therapies and preventive strategies for the many challenging viruses we face. Institutions and scientists who work together can accomplish a great deal more than can any researcher or organization working individually.”

Numerous components of Emory’s Woodruff Health Sciences Center (including the Emory Vaccine Center, the Emory Center for AIDS Research, Yerkes National Primate Research Center, the Emory Global Health Institute, Emory Institute for Drug Development, Tropical Infectious Diseases Program, Virology and Molecular Biomarkers Core, Atlanta Clinical and Translational Science Institute, Prevention Research Center), and the Emory schools of medicine, public health and nursing all have contributed to the development of successful programs in virology that span basic laboratory research, clinical research, and behavioral science. Emory University has established collaborations with other Atlanta-based universities including Georgia Institute of Technology (Georgia Tech Partnership) and Morehouse School of Medicine (Prevention Research Center, PRC).

“Our programs in virology, including education, research, and patient care, have contributed to lifesaving global advances, and we are very pleased to contribute our knowledge, expertise and partnership to the future efforts of the GVN,” says del Rio.

The GVN is a global authority and resource for the identification and investigation, interpretation and explanation, control and suppression, of viral diseases posing threats to mankind. It enhances the international capacity for reactive, proactive and interactive activities that address mankind-threatening viruses and addresses a global need for coordinated virology training, developing scholarly exchange programs for recruiting and training young scientists in medical virology. The GVN also serves as a resource to governments and international organizations seeking advice about viral disease threats, prevention or response strategies and GVN advocates for research and training on virus infections and their many disease manifestations.

Dr. Robert Gallo is presenting the Raymond Schinazi Distinguished Lecture at 4 p.m. today on “Virus Epidemics with Special Emphasis on HIV and AIDS: Reflections on the Past and Prospects for the Future.” It will be held at Emory’s Health Sciences Research Building Auditorium, 1760 Haygood Drive, Atlanta, GA 30322 and is free and open to the Emory community and the public.

Gallo will present reflections on the past and areas where we might have done better. He will discuss the great contributions in the field of HIV research and where we are today as well as a view of the key problems for the future. He will provide background on the special aspects of this kind of virus, namely a retrovirus, and his earlier discovery of the first known human retroviruses, human T cell leukemia virus-1, or HTLV-1, as well as HTLV-2.  He will end his lecture presenting on the direction research is headed, the Institute of Human Virology’s HIV vaccine, including where it is today (phase 1 human clinical trials) and the difficulties facing the field in the future.

About Emory University

Emory University, located in Atlanta, GA, encompasses outstanding undergraduate institutions, highly ranked professional schools and state-of-the-art research facilities. Emory includes nine academic divisions as well as The Carter Center, the Yerkes National Primate Research Center, the Michael C. Carlos Museum, and Emory Healthcare, Georgia’s largest and most comprehensive health care system. Emory University Hospital has affiliations with Grady Hospital (urban Community Hospital) and close proximity and collaborations with the adjacent U.S. Centers for Disease Control and Prevention and the Atlanta Veterans Affairs Medical Center.

Top Virologists Meet in China to Address Threats

Top Virologists of the Global Virus Network (GVN) Meet in China to Address Threats

The Addition of Two GVN Centers of Excellence Strengthen GVN’s Worldwide Reach

Baltimore, Maryland, USA, May 11, 2015: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, in partnership with Beijing University of Technology, a GVN Center of Excellence, will host its 7th meeting of top virologists May 16-19, 2015 in Beijing, China. The announcement was made today by Robert Gallo, MD, GVN Co-Founder and Scientific Director, Yi Zeng, MD, PhD, GVN China’s Center of Excellence Director and the GVN President. They also announced the addition of two new GVN Centers of Excellence including the University at Buffalo (UB), State University of New York (SUNY), USA and the Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain. Since its founding in 2011, GVN has grown to include 34 Centers of Excellence in 24 countries, comprising expertise in all classes of human viruses.

“I am pleased to join my friend and colleague, Professor Yi Zeng, in hosting this important meeting as these personal, face-to-face interactions among our colleagues are integral to sharing information and inspiring international collaborations that otherwise might not exist,” said Dr. Robert Gallo, Director of the Institute of Human Virology at the University of Maryland School of Medicine, a GVN Center of Excellence. “China has been involved with GVN from the very inception, and Professor Yi Zeng has been and continues to be a valued and honored GVN leader as well as a member of the Scientific Leadership Board, which reviews all prospective Centers.“

“China is honored to host this meeting of the GVN,” said Professor Yi Zeng, Honorary Dean at the College of Life Sciences and Bioengineering at Beijing University of Technology and Chief Scientist and Professor at the Institute of Viral Diseases Control and Prevention China, a GVN Center of Excellence. “We are committed to working closely with our colleagues at the GVN and strengthening ties with the internationally renowned scholars who comprise the network.”

Members of the GVN will exchange ideas on viruses including HPV and Esophageal Carcinoma, Hepatitis, HIV/AIDS, emerging viruses, Measles, MERS, Dengue, Chikungunya, HTLV, Influenza, Hemorrhagic Fever viruses – including Ebola, among other viruses, and viral diagnostics. Other prominent virologists participating in the meeting include Dianne Griffin, MD, PhD of GVN’s Center of Excellence at Johns Hopkins Bloomberg School of Public Health, USA, who is a renowned measles expert and Ab Osterhaus, DVM, PhD, of GVN’s Center of Excellence at University of Veterinary Medicine, Germany, who is a renowned coronavirus expert (SARS, MERS). They will discuss many viral challenges China shares with other nations, including the rise of measles and the threat of coronaviruses.

“We are honored to be hosted in China, where the tradition of supporting virology in China is strong and the tradition of international cooperation stronger still,” added GVN’s President.   ”This meeting in China paves the way for onward collaborations and strengthening of our global safety net against viral disease threats. It is the first time that the GVN has met outside of the U.S. or Europe, and we are delighted to be in Asia.”

The GVN is an essential and critical defense against viral disease. It is a coalition comprised of world renowned virologists, all working to advance knowledge about how viruses cause disease, to develop drugs and vaccines to prevent illness and death, and to train the next generation of virus researchers. GVN is the only institution in the world that has expertise in all classes of human viruses.

 

Moscow Meeting of Top Virus Researchers Catalyzes Global Collaborations

September 26, 2013 11:41 AM Eastern Daylight Time

BALTIMORE–(BUSINESS WIRE)–Members of the Global Virus Network (GVN), which includes foremost experts in every class of human virus, and represents more than 20 countries, met in Moscow this month to share information on devastating viral threats. Top scientists shared intelligence on an array of diseases threatening global health, including China’s H7N9 influenza epidemic, the alarming rise in measles cases in Europe and the United States, the unexpected re-emergence of polio, and insidious viruses causing cancer lymphomas, to name a few. Robert C. Gallo, MD, GVN Co-Founder and Scientific Director, said, “The scientific presentations at the meeting were terrific and varied. The meeting helped forge collaborations around the world that might not otherwise exist. For example, during the meeting we launched an important training program between researchers and clinicians at our Institute in Baltimore and with those in Moscow and surrounding regions in Russia.”

“Research presented in Moscow was very stimulating, and Moscow served as a catalyst for scientific collaborations that would not otherwise have been initiated”

Newly elected Chairman of the GVN Board of Directors ,Chief Executive Officer of Burrill & Company, said, “What once was a regional epidemic today grows exponentially into a global threat due to international travel, trade and other factors. A strong, interconnected network of medical virologists – a GVN – is mankind’s best defense against new and existing viral threats.” Burrill continued, “In Moscow, we strengthened our network through scientist-to-scientist exchanges on drug and vaccine development on a range of critical viral diseases, including HIV/AIDS, hepatitis, measles, influenza, enterovirus, polio hemorrhagic fever and the 20% of cancers caused by viruses. Face-to-face meetings of scientists are essential in pushing knowledge forward. Our gathering of world leaders in medical virology is a vital element to success against viral foes.”

Co-founded in 2011 by Dr. Gallo, most widely known for his pioneering discoveries of the first human retroviruses, co-discovery of HIV as the cause of AIDS, and development of the HIV blood test, and his colleagues William Hall, MD, PhD, Chair of Medical Microbiology and Director of the Centre for Research in Infectious Diseases at University College Dublin’s (UCD) School of Medicine and Medical Science in Dublin, Ireland, and Reinhard Kurth, MD, former Director of the Paul Ehrlich Institute and the Robert Koch Institute and Chairman of the Foundation Council at Ernst Schering Foundation in Berlin, Germany, GVN fulfills the need for substantive increases in global collaboration to overcome gaps in research during the earliest phases of viral epidemics and medical training programs enhancing the numbers of rising medical virologists trained to meet these challenges.

“Research presented in Moscow was very stimulating, and Moscow served as a catalyst for scientific collaborations that would not otherwise have been initiated,” said Gallo, also Director of the Institute of Human Virology at the University of Maryland School of Medicine. “We are all very grateful to our GVN Russian Center of Excellence Head and host of the meeting, Alexey Mazus, MD, Chief Expert on HIV/AIDS for the Russian Federation Ministry of Health and Head of the Moscow Center for HIV/AIDS Prevention and Treatment. We look forward to launching our new collaboration.”

GVN President welcomed the announcement by Dr. Mazus explaining that the Institute of Human Virology at the University of Maryland School of Medicine will serve as the first training site for young Russian scientists.  The President continued,  “In addition to training in clinical virology, we hope to expand our relationship with the Russian GVN to include training for post-doctoral research fellows and other scholarships in medical virology, building on the strong foundation in virology already present in Russia.”

In addition to the Russian GVN and IHV GVN Center of Excellence collaboration announcement, IHV Associate Director and Director of the Clinical Care and Research Division, Robert Redfield, MD and his John Hopkins University colleague John Bartlett, MD and Dr. Mazus released a Russian clinical training book, “Medical Management of HIV Infection,” in partnership with the GVN.

GVN will hold its next meeting in Xi’an, China in May 2014.